Publications by authors named "Graham Cohen"

Claim this Profile
P
Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18.
Graham L Cohen, Corlia Coetzee, Cathryn A Walton, Òscar Reig Torras, Byoung Chul Cho, Julia W Cohen

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study.
Graham Cohen, Bernardo Rapoport, Sze W Chan, Paul Ruff, Ana Arance

PLoS One· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial.
Thomas Powles, Yen-Hwa Chang, Yoshiaki Yamamoto, Jose Munoz, Felipe Reyes-Cosmelli, Graham Cohen

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer.
John V Heymach, Luis Paz-Ares, Filippo De Braud, Martin Sebastian, David J Stewart, Graham Cohen

J Clin Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis